Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.

@article{Fangmann2008HalfAC,
  title={Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.},
  author={Peter Fangmann and H. J. Assion and Georg Juckel and C {\'A}lamo Gonz{\'a}lez and Francisco Javier L{\'o}pez-Mu{\~n}oz},
  journal={Journal of clinical psychopharmacology},
  year={2008},
  volume={28 1},
  pages={
          1-4
        }
}
FIVE DECADES OF ANTIDEPRESSANTS The 50th anniversary of antidepressive pharmacotherapy is worth commemorating. In 2 parts, we review the onset of drug treatment with convincing antidepressive efficacy, and in this second part, we recap the development and clinical introduction of tricyclics and tetracyclics. In speaking with Gerhart Harrer, who reviewed his own experience, he said, BThe introduction of antidepressants meant an enrichment for doctor’s therapeutic possibilities which matched a… 
History of the Discovery of Antidepressant Drugs
TLDR
The clinical introduction of fluoxetine, a selective serotonin reuptake inhibitor, in the late 1980s, once again revolutionized therapy for depression, opening the way for new families of antidepressants.
Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.
TLDR
The present work reviews, from a historical perspective, the entire process that led to the discovery of these drugs, as well as their contribution to the development of the neuroscientific disciplines.
A brief history of antidepressant drug development: from tricyclics to beyond ketamine
TLDR
A historical review of the development of monoaminergic antidepressant drugs and the role of ketamine as the introductory agent of a new era in the research of the neurobiology of depression and how it revealed itself as an exciting option towards obtaining pharmacological agents to treat depression, through the understanding of biological markers.
Ketamine ’ s Legacy : New Targets for the Development of Rapid onset Antidepressant Drugs
TLDR
Ketamine seems to be the prototype for a new generation of antidepressants that can impact the clinical management of depression exerting their therapeutic effects within hours, especially in situations of treatment-resistant depression.
A brief history of the development of antidepressant drugs: from monoamines to glutamate.
TLDR
The noncompetitive NMDA receptor antagonist ketamine, which has consistently produced rapid and sustained antidepressant effects in MDD patients in a number of clinical studies, has shown the most promise as a novel glutamatergic-based treatment for MDD.
A History of the Pharmacological Treatment of Bipolar Disorder
TLDR
The history of the pharmacological treatment of bipolar disorder is reviewed, from the first nonspecific sedative agents introduced in the 19th and early 20th century to the beginning of the so-called “Psychopharmacological Revolution” in the 1950s.
Antidepressants: From MAOIs to SSRIs and more
TLDR
The era of antidepressants started with isoniazid, an antitubercular agent, which was accidentally found to have euphoric effects in patients with tuberculosis who were receiving this drug, which became the primary effect in depression and heralded the synthesis of generations of newer antidepressants.
The Rise of Effective Treatments
TLDR
At the beginning these drugs received limited attention by the pharmaceutical industry but were soon developed and accepted as effective treatments of severe mood disorders and opened the way to newer and safer medicines and antidepressants.
[Update Opipramol].
TLDR
In view of the limited availability of (pharmacologic) treatment options for generalized anxiety disorder and particularly somatoform disorders, opipramol should be considered in the treatment of these entities.
...
...

References

SHOWING 1-10 OF 25 REFERENCES
Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
TLDR
The onset of drug treatment with convincing antidepressive efficacy in 2 parts is reviewed, and a recapitulate on the development and clinical introduction of monoamine oxidase inhibitors (MAOI).
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
TLDR
The most important progress in the past 10 years has been the development of compounds which possess markedly reduced binding capacities at receptor sites not linked to their antidepressive actions.
Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials
TLDR
Amitriptyline is less well tolerated than tricyclics/heterocyclics and SSRIs, but slightly more patients treated on it recover than on alternative antidepressants.
The Treatment of Depressive Conditions with Imipramine (G 22355) *
TLDR
It is concluded that Imipramine (G 22355) is a relatively non-toxic drug useful in the treatment of depressions, especially of the endogenous type.
Preliminary Evaluation of a New Anti-Depressant, Trimipramine, by a Sequential Method
  • B. Burns
  • Psychology, Medicine
    British Journal of Psychiatry
  • 1965
TLDR
A three weeks' comparative trial between this drug and imipramine (Tofranil), in the treatment of psychotic depression, using the statistical method of sequential analysis, the actual design used was that at the 5 per cent.
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac
TLDR
This biography is informative and com prehensive in its coverage of Jung's personal and public life, however, it emphasises his significance today as guru of New Age interest in Eastern thought, the paranormal and astrology, rather than recognising his place in the contemporary psychoanalytic and psychotherapeutic world.
A Controlled Trial with Trimipramine, a New Anti-Depressant Drug
This paper describes a double blind controlled trial of the compound trimipramine ('Surmontil’), which does not appear hitherto to have been reported upon by the English-speaking investigators,
The place of clomipramine in the development of psychopharmacology
TLDR
Start from the start My career has been very varied but I began by wanting to become an obstetrician and gynaecologist and went quite a long way along that path but then became disenchanted because some of my colleagues, who were then senior registrars, were not getting consultant appointments until their early 40s.
Comparative cannabis use data
TLDR
It is claimed that the Dutch experience (the coffee shop system with decriminalisation of purchase, followed by “commercial promotion”) significantly increases cannabis use prevalence.
Declarations of interest
TLDR
2.2.1 Development Services Section Application Statistics December 2009 59 3.2 Unequal Standards for Joint Regional Planning Panel (JRPP) Representatives 60 3.3 Bolger Street, Campbelltown Construction of Additions to Existing Licensed Premises 64.
...
...